NovoCure (NVCR) Revenue Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.26% |
| Dec 31, 2025 | 3.91% |
| Sep 30, 2025 | 4.74% |
| Jun 30, 2025 | 6.50% |
| Mar 31, 2025 | 8.77% |
| Dec 31, 2024 | 10.20% |
| Sep 30, 2024 | 11.00% |
| Jun 30, 2024 | 11.64% |
| Mar 31, 2024 | 13.57% |
| Dec 31, 2023 | 13.94% |
| Sep 30, 2023 | 14.48% |
| Jun 30, 2023 | 15.43% |
| Mar 31, 2023 | 18.57% |
| Dec 31, 2022 | 19.07% |
| Sep 30, 2022 | 21.19% |
| Jun 30, 2022 | 29.70% |
| Mar 31, 2022 | 31.58% |
| Dec 31, 2021 | 34.52% |
| Sep 30, 2021 | 43.87% |
| Jun 30, 2021 | 49.43% |
| Mar 31, 2021 | 59.49% |
| Dec 31, 2020 | 63.33% |
| Sep 30, 2020 | 71.46% |
| Jun 30, 2020 | 77.70% |
| Mar 31, 2020 | 81.23% |
| Dec 31, 2019 | 92.02% |
| Sep 30, 2019 | 83.92% |